Kate Rochlin - Net Worth and Insider Trading
Kate Rochlin Net Worth
The estimated net worth of Kate Rochlin is at least $1,690 dollars as of 2024-09-20. Kate Rochlin is the COO of IN8bio Inc and owns about 5,263 shares of IN8bio Inc (INAB) stock worth over $1,690. Details can be seen in Kate Rochlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kate Rochlin has not made any transactions after 2022-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kate Rochlin
Kate Rochlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kate Rochlin owns 1 companies in total, including IN8bio Inc (INAB) .
Click here to see the complete history of Kate Rochlin’s form 4 insider trades.
Insider Ownership Summary of Kate Rochlin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INAB | IN8bio Inc | 2022-08-16 | Chief Operating Officer |
Kate Rochlin Latest Holdings Summary
Kate Rochlin currently owns a total of 1 stock. Kate Rochlin owns 5,263 shares of IN8bio Inc (INAB) as of August 16, 2022, with a value of $1,690.
Latest Holdings of Kate Rochlin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INAB | IN8bio Inc | 2022-08-16 | 5,263 | 0.32 | 1,690 |
Holding Weightings of Kate Rochlin
Kate Rochlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Kate Rochlin has made a total of 1 transactions in IN8bio Inc (INAB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IN8bio Inc is the acquisition of 5,263 shares on August 16, 2022, which cost Kate Rochlin around $10,000.
Insider Trading History of Kate Rochlin
- 1
Kate Rochlin Trading Performance
GuruFocus tracks the stock performance after each of Kate Rochlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kate Rochlin is -17.96%. GuruFocus also compares Kate Rochlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kate Rochlin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kate Rochlin's insider trading performs compared to the benchmark.
Performance of Kate Rochlin
Kate Rochlin Ownership Network
Kate Rochlin Owned Company Details
What does IN8bio Inc do?
Who are the key executives at IN8bio Inc?
Kate Rochlin is the Chief Operating Officer of IN8bio Inc. Other key executives at IN8bio Inc include Chief Financial Officer Patrick Mccall , director & President & CEO and CFO William Tai-wei Ho , and director & 10 percent owner Bios Fund Ii, Lp .
IN8bio Inc (INAB) Insider Trades Summary
Over the past 18 months, Kate Rochlin made no insider transaction in IN8bio Inc (INAB). Other recent insider transactions involving IN8bio Inc (INAB) include a net purchase of 23,800 shares made by William Tai-wei Ho , a net purchase of 2,500 shares made by Jeremy R. Graff , and a net purchase of 1,000 shares made by Patrick Mccall .
In summary, during the past 3 months, insiders sold 0 shares of IN8bio Inc (INAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IN8bio Inc (INAB) were sold and 27,300 shares were bought by its insiders, resulting in a net purchase of 27,300 shares.
IN8bio Inc (INAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
IN8bio Inc Insider Transactions
Kate Rochlin Mailing Address
Above is the net worth, insider trading, and ownership report for Kate Rochlin. You might contact Kate Rochlin via mailing address: In8bio, Inc., Empire State Building, Suite 5330, New York Ny 10118.